News

In clinical trials, insulin analogs modestly reduced the risk of nocturnal hypoglycemia, or low blood sugar during sleep, compared with human insulin. “The problem is that insulin analogs are much ...
Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...
These insulin analogs had to go the standard FDA required trials to demonstrate safety and efficacy, just like any other experimental medicine. As is the norm, these new drugs were patented.
To compare insulin analogs with NPH insulin, Lipska, Karter and their colleagues followed the new insulin users with type 2 diabetes for an average of 1.7 years.
Insulin analogs have also been shown to improve patients’ health-related quality of life (QOL) relative to human insulins. 41,42 Because QOL is an important determinant of adherence, ...
Background: Although insulin analogues are commonly prescribed for the management of diabetes mellitus, there is uncertainty regarding their optimal use. We conducted meta-analyses to compare the ...
Analog insulin use predominated and accounted for more than 80% of total treatment visits across all years In 2016, newer insulins were used in 18.1% of total treatment visits and rose in ...
Brazil's Health Ministry took delivery on Friday of the first batch of insulin produced through the Partnerships for ...
The drug at the heart of the studies is called icodec, an insulin analog with a half-life of 196 hours – a little over eight days. Developed by Novo Nordisk, ...
For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs vs. other basal insulin therapies.
Woman-Diabetes-Insulin_G_645403776 Compared with human neutral protamine Hagedorn insulin, basal insulin analogs do not reduce risk of hypoglycemia-linked ED visits or hospital admissions in T2D.
"Technosphere insulin has a unique delivery method, bioavailability, and pharmacodynamics leading to a very different clinical effect per unit compared to rapid-acting analogs." ...